Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of TRC101, a non-absorbed orally-administered polymer drug that has completed Phase III clinical trials to treat metabolic acidosis in patients with chronic kidney disease. The company was founded in 2013 and is headquartered in South San Francisco, California.

Receive TCDA News and Ratings via Email

Sign-up to receive the latest news and ratings for TCDA and its competitors with MarketBeat's FREE daily newsletter.

Profitability

Miscellaneous

Tricida (NASDAQ:TCDA) Frequently Asked Questions

What is Tricida's stock symbol?

Tricida trades on the NASDAQ under the ticker symbol "TCDA."

How were Tricida's earnings last quarter?

Tricida Inc (NASDAQ:TCDA) released its quarterly earnings results on Thursday, November, 8th. The company reported ($0.65) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.84) by $0.19. View Tricida's Earnings History.

When is Tricida's next earnings date?

What price target have analysts set for TCDA?

3 Wall Street analysts have issued 12-month price objectives for Tricida's shares. Their predictions range from $32.00 to $50.00. On average, they anticipate Tricida's share price to reach $38.6667 in the next year. This suggests a possible upside of 76.1% from the stock's current price. View Analyst Price Targets for Tricida.

What is the consensus analysts' recommendation for Tricida?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tricida in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Tricida.

Has Tricida been receiving favorable news coverage?

Media coverage about TCDA stock has been trending very positive on Monday, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Tricida earned a news impact score of 3.2 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 4.0 out of 10, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

Are investors shorting Tricida?

Tricida saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 1,827,972 shares, an increase of 64.2% from the December 14th total of 1,113,350 shares. Based on an average daily trading volume, of 296,733 shares, the days-to-cover ratio is currently 6.2 days. Currently, 6.7% of the company's stock are short sold. View Tricida's Current Options Chain.

When did Tricida IPO?

(TCDA) raised $175 million in an initial public offering (IPO) on Thursday, June 28th 2018. The company issued 10,300,000 shares at a price of $16.00-$18.00 per share. Goldman Sachs, J.P. Morgan and Cowen acted as the underwriters for the IPO.

When did Tricida's lock-up period expire?

Tricida's lock-up period expired on Tuesday, December 25th. Tricida had issued 11,700,000 shares in its initial public offering on June 28th. The total size of the offering was $222,300,000 based on an initial share price of $19.00. Since the end of Tricida's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company have been lifted.

How do I buy shares of Tricida?

Shares of TCDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tricida's stock price today?

One share of TCDA stock can currently be purchased for approximately $21.96.

How big of a company is Tricida?

Tricida has a market capitalization of $924.66 million. Tricida employs 61 workers across the globe.

MarketBeat Community Rating for Tricida (NASDAQ TCDA)

MarketBeat's community ratings are surveys of what our community members think about Tricida and other stocks. Vote "Outperform" if you believe TCDA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TCDA will underperform the S&P 500 over the long term. You may vote once every thirty days.